(CHD) Church & Dwight - Ratings and Ratios
Baking Soda, Laundry Detergent, Toothpaste, Condoms, Supplements
CHD EPS (Earnings per Share)
CHD Revenue
Description: CHD Church & Dwight October 16, 2025
Church & Dwight Co. (NYSE: CHD) manufactures and markets a diversified portfolio of household, personal-care, and specialty products across three operating segments-Consumer Domestic, Consumer International, and Specialty Products. Its flagship ARM & HAMMER line spans baking-soda-based cleaners, cat litter, and laundry detergents, while the TROJAN brand dominates the condom market and OXICLEAN supplies stain-removing solutions. The company also sells niche health-care items (e.g., FIRST RESPONSE pregnancy tests) and animal-nutrition additives such as BIO-CHLOR and CERTILLUS.
In FY 2023 the firm reported revenue of roughly $5.5 billion, with the ARM & HAMMER household segment contributing about 55 % of sales and delivering an operating margin near 17 %. Net income grew 8 % year-over-year, reflecting modest pricing power in a high-inflation environment and cost-saving initiatives in its supply chain. The specialty animal-feed division, though only ~5 % of total revenue, has a higher gross margin (≈30 %) and benefits from rising protein-demand in emerging markets-a key sector driver.
CHD’s distribution model blends traditional brick-and-mortar channels (supermarkets, mass merchandisers, drugstores) with expanding e-commerce platforms, a trend that has accelerated post-COVID and now accounts for roughly 12 % of total sales. Assuming continued consumer-goods inflation stays within the 3-4 % range, the company’s pricing elasticity suggests earnings could sustain a 5-6 % annual growth rate, but a slowdown in discretionary spending would materially pressure margins.
For a deeper dive into CHD’s valuation metrics and scenario analysis, the ValueRay platform offers a concise, data-driven overview.
CHD Stock Overview
| Market Cap in USD | 20,924m |
| Sub-Industry | Household Products |
| IPO / Inception | 1986-03-06 |
CHD Stock Ratings
| Growth Rating | -6.10% |
| Fundamental | 69.6% |
| Dividend Rating | 52.4% |
| Return 12m vs S&P 500 | -31.2% |
| Analyst Rating | 3.42 of 5 |
CHD Dividends
| Dividend Yield 12m | 1.43% |
| Yield on Cost 5y | 1.41% |
| Annual Growth 5y | 4.30% |
| Payout Consistency | 92.0% |
| Payout Ratio | 50.6% |
CHD Growth Ratios
| Growth Correlation 3m | -73.5% |
| Growth Correlation 12m | -84% |
| Growth Correlation 5y | 67.5% |
| CAGR 5y | 5.43% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.20 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.88 |
| Sharpe Ratio 12m | 0.55 |
| Alpha | -28.86 |
| Beta | 0.425 |
| Volatility | 19.98% |
| Current Volume | 2518.9k |
| Average Volume 20d | 1990.9k |
| Stop Loss | 79.3 (-3.1%) |
| Signal | -0.77 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (525.2m TTM) > 0 and > 6% of Revenue (6% = 364.0m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 1.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.83% (prev 10.09%; Δ 6.74pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 1.07b > Net Income 525.2m (YES >=105%, WARN >=100%) |
| Net Debt (1.49b) to EBITDA (1.02b) ratio: 1.46 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (247.2m) change vs 12m ago 0.08% (target <= -2.0% for YES) |
| Gross Margin 44.47% (prev 45.46%; Δ -0.99pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 69.13% (prev 68.46%; Δ 0.67pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 8.31 (EBITDA TTM 1.02b / Interest Expense TTM 93.6m) >= 6 (WARN >= 3) |
Altman Z'' 5.44
| (A) 0.12 = (Total Current Assets 2.23b - Total Current Liabilities 1.21b) / Total Assets 8.79b |
| (B) 0.75 = Retained Earnings (Balance) 6.59b / Total Assets 8.79b |
| (C) 0.09 = EBIT TTM 777.9m / Avg Total Assets 8.78b |
| (D) 1.56 = Book Value of Equity 6.86b / Total Liabilities 4.39b |
| Total Rating: 5.44 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 69.61
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.15% = 2.08 |
| 3. FCF Margin 15.34% = 3.84 |
| 4. Debt/Equity 0.55 = 2.35 |
| 5. Debt/Ebitda 1.46 = 1.03 |
| 6. ROIC - WACC (= 2.14)% = 2.67 |
| 7. RoE 12.01% = 1.00 |
| 8. Rev. Trend 73.42% = 5.51 |
| 9. EPS Trend -7.23% = -0.36 |
What is the price of CHD shares?
Over the past week, the price has changed by -7.13%, over one month by -5.02%, over three months by -15.15% and over the past year by -17.71%.
Is Church & Dwight a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CHD is around 69.71 USD . This means that CHD is currently overvalued and has a potential downside of -14.82%.
Is CHD a buy, sell or hold?
- Strong Buy: 7
- Buy: 2
- Hold: 10
- Sell: 4
- Strong Sell: 1
What are the forecasts/targets for the CHD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 96.7 | 18.2% |
| Analysts Target Price | 96.7 | 18.2% |
| ValueRay Target Price | 76.6 | -6.4% |
CHD Fundamental Data Overview October 28, 2025
P/E Trailing = 40.3962
P/E Forward = 23.3645
P/S = 3.4493
P/B = 4.9013
P/EG = 2.0336
Beta = 0.425
Revenue TTM = 6.07b USD
EBIT TTM = 777.9m USD
EBITDA TTM = 1.02b USD
Long Term Debt = 2.21b USD (from longTermDebt, last quarter)
Short Term Debt = 30.3m USD (from shortTermDebt, last quarter)
Debt = 2.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.49b USD (from netDebt column, last quarter)
Enterprise Value = 22.41b USD (20.92b + Debt 2.41b - CCE 923.2m)
Interest Coverage Ratio = 8.31 (Ebit TTM 777.9m / Interest Expense TTM 93.6m)
FCF Yield = 4.15% (FCF TTM 930.6m / Enterprise Value 22.41b)
FCF Margin = 15.34% (FCF TTM 930.6m / Revenue TTM 6.07b)
Net Margin = 8.66% (Net Income TTM 525.2m / Revenue TTM 6.07b)
Gross Margin = 44.47% ((Revenue TTM 6.07b - Cost of Revenue TTM 3.37b) / Revenue TTM)
Gross Margin QoQ = 42.95% (prev 44.96%)
Tobins Q-Ratio = 2.55 (Enterprise Value 22.41b / Total Assets 8.79b)
Interest Expense / Debt = 0.98% (Interest Expense 23.5m / Debt 2.41b)
Taxrate = 23.75% (59.5m / 250.5m)
NOPAT = 593.1m (EBIT 777.9m * (1 - 23.75%))
Current Ratio = 1.84 (Total Current Assets 2.23b / Total Current Liabilities 1.21b)
Debt / Equity = 0.55 (Debt 2.41b / totalStockholderEquity, last quarter 4.39b)
Debt / EBITDA = 1.46 (Net Debt 1.49b / EBITDA 1.02b)
Debt / FCF = 1.60 (Net Debt 1.49b / FCF TTM 930.6m)
Total Stockholder Equity = 4.37b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.98% (Net Income 525.2m / Total Assets 8.79b)
RoE = 12.01% (Net Income TTM 525.2m / Total Stockholder Equity 4.37b)
RoCE = 11.82% (EBIT 777.9m / Capital Employed (Equity 4.37b + L.T.Debt 2.21b))
RoIC = 9.01% (NOPAT 593.1m / Invested Capital 6.58b)
WACC = 6.87% (E(20.92b)/V(23.33b) * Re(7.58%) + D(2.41b)/V(23.33b) * Rd(0.98%) * (1-Tc(0.24)))
Discount Rate = 7.58% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 0.04%
[DCF Debug] Terminal Value 78.48% ; FCFE base≈872.1m ; Y1≈883.8m ; Y5≈962.9m
Fair Price DCF = 69.75 (DCF Value 16.99b / Shares Outstanding 243.6m; 5y FCF grow 1.01% → 3.0% )
EPS Correlation: -7.23 | EPS CAGR: 8.04% | SUE: 0.22 | # QB: 0
Revenue Correlation: 73.42 | Revenue CAGR: 5.00% | SUE: 0.79 | # QB: 0
Additional Sources for CHD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle